AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇿🇼
ABIRATERONE ACETATE in Zimbabwe
4 products registered with MCAZ — 4 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| ABIRAPRO 500MG TABLET, COATED; ORAL | 2025/9.5.2/6800 | GLENMARK PHARMACEUTICAL LIMITED | active | 6 Jan 2030 |
| BIRATO 250 TABLET; ORAL | 2020/9.5.2/5970 | MSN LABORATORIES PRIVATE LIMITED | active | 28 Aug 2029 |
| ZYTIGA 250 TABLET; ORAL | 2016/9.5.2/5202 | JANSSEN PHARMACEUTICA (PTY) LTD | active | 31 Dec 2027 |
| ABIRANNOVA TABLET, COATED; ORAL | 2025/9.5.2/7101 | INNOVATA PHARMACEUTICALS | active | 31 Dec 2027 |
ABIRATERONE ACETATE — MCAZ Registration Details
MCAZ (Zimbabwe) has 4 registered products containing ABIRATERONE ACETATE, of which 4 are currently active. Data is sourced directly from the official MCAZ drug register and refreshed daily.
Track ABIRATERONE ACETATE registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.